TEL AVIV, Israel, Nov. 5, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today positive preclinical results further elucidating the mechanism of action of BL-8040 in combination with an anti PD-1 and chemotherapy. The results, summarized in

BOCA RATON, Florida, Nov. 5, 2019 /PRNewswire/ -- Smart Decision, Inc. (OTC Pink Markets: SDEC), a next-generation consumer-based LED & CBD algorithm innovator, is pleased to announce that it has signed a Letter of Intent (LOI) with LBC Bioscience Inc., a visionary in the CBD space.  "In recent weeks, we have been fortunate enough to sign Letters of

BOSTON, Nov. 5, 2019 /PRNewswire/ -- BV Investment Partners ("BV"), a middle-market private equity firm focused on the business services, software and IT services sectors, today announced that it has acquired EDCO Health Information Solutions Inc. ("EDCO" or the "Company"). BV is partnering with the current executive team of EDCO.

In the news release, Avantor Reports Third Quarter 2019 Results, issued 05-Nov-2019 by Avantor and Financial News over PR Newswire, we are advised by the company that the first paragraph, first sentence of the Full-Year 2019 Outlook section should read "The Company expects net sales in the range of $6.02-6.08 billion, representing growth of 2.7-3.7%, or 5.0%-6.0% on an orga

NEWPORT BEACH, Calif., Nov. 5, 2019 /PRNewswire/ -- Chipotle Mexican Grill (NYSE: CMG) announced today that it will be providing access to mental healthcare and financial wellness for more than 80,000 employees in 2020 through Employee Assistance Programs and enhanced benefits offerings. This is just one of the many ways that

SACRAMENTO, Calif., Nov. 5, 2019 /PRNewswire/ -- Earlier this month, the state of California took a decisive step in favor of clear and simple credit products by signing SB-639 into law.  When this bill takes effect in July of 2020, it will prohibit medical and veterinary clinics and their employees from arranging for or establishing

In the news release, Sojournix to Present at Stifel 2019 Healthcare Conference, issued 05-Nov-2019 by Sojournix over PR Newswire, we are advised by the company that the conference date in paragraph 1 was incorrect and should read "Wednesday, November 20" rather than "Tuesday, November 9" as originally issued inadvertently. The complete, corrected release follows:Sojournix to Present at Stifel 20

FREEHOLD, N.J., Nov. 5, 2019  /PRNewswire/ --The nation spent $35 billion annually on addiction treatment, and  had little to show for it, as the opioid epidemic ballooned over two decades claiming nearly 200 lives each day. "Although treatment availability expanded over the years, it was more of the same inpatient tr

VANCOUVER, Nov. 5, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application ("CTA") in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers.

SALT LAKE CITY, Nov. 5, 2019 /PRNewswire/ -- Researchers from